| Abexinostat studied in …STUDIED_INderived14 of 14show fewer |
|---|
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · 14 trials list this drug (6 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligodendroglioma,Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027910Phase 1/Phase 2 · completed PCI-24781 in Combination With Doxorubicin to Treat Sarcoma · 14 trials list this drug (6 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03939182Phase 1 · completed Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma · 14 trials list this drug (6 active) | — | — | Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03592472Phase 3 · recruiting A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) · 14 trials list this drug (6 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600441Phase 2 · active not recruiting Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma · 14 trials list this drug (6 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03934567Phase 2 · active not recruiting A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma · 14 trials list this drug (6 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03936153Phase 2 · recruiting Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) · 14 trials list this drug (6 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024696Phase 1/Phase 2 · active not recruiting A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients · 14 trials list this drug (6 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590054Phase 1 · completed Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies · 14 trials list this drug (6 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498520Phase 1 · withdrawn Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer · 14 trials list this drug (6 active) | — | — | Malignant Solid Neoplasm,Breast Carcinoma,Endometrioid Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00724984Phase 1/Phase 2 · completed Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma · 14 trials list this drug (6 active) | — | — | Lymphoma,Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149668Phase 1 · completed A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer · 14 trials list this drug (6 active) | — | — | Leukemia,Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562224Phase 1 · completed Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients · 14 trials list this drug (6 active) | — | — | Neoplasm by Site,Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00473577Phase 1 · completed Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients · 14 trials list this drug (6 active) | — | — | Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |